Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

PHILADELPHIA (April 27, 2023)—Fox Chase Cancer Center and Temple Health are pleased to announce the new Fox Chase-Temple Urologic Institute, a groundbreaking initiative that...

Tom, who failed to invite a guest, quizzes Brian on the new data from the meeting he...

We identified significant gaps in adoption of female ROS and nerve-sparing RC techniques for patients with organ-confined disease, despite evidence that ROS and nerve-sparing...

Mashup Score:32

GU Oncology Now

AUA 2023 | GU Oncology Now - 1 month

Mashup Score:32

Read in-depth coverage of the AUA 2023 Annual Meeting, featuring the latest research and science on urology from GU oncology experts and key opinion...

Despite its low-risk nature, grade group 1 (GG 1) prostate cancer (PCa) remains overtreated. This suggests a disconnect between daily physician...

AUA 2023, SunRISe-1 trial, Bacillus Calmette-Guerin (BCG), BCG Unresponsive High-Risk Non–muscle-Invasive Bladder Cancer (NMIBC), TAR-200 in Combination With Cetrelimab, TAR-200 monotherapy, Cetrelimab, gemcitabine, efficacy...

This case series investigated the rate of prostate cancer diagnoses among transgender women treated in the Veterans Affairs health...

METHOD OF PARTICIPATION:Learners will participate in this online educational activity by taking the pretest, viewing the webcast and/or listening to the podcast and completing the...

Life 3.0: Being Human in the Age of Artificial Intelligence [Tegmark, Max] on Amazon.com. *FREE* shipping on qualifying offers. Life 3.0: Being Human in...

A prostate cancer debate between Dr. Catalona and Dr. Cooperberg considered renaming Gleason 6 to remove the cancer...